论文部分内容阅读
为了找到一种鉴别诊断卵巢癌与卵巢囊肿的检验指标，应用IMX全自动微粒子酶免疫分析仪测定了36例卵巢癌，32例卵巢囊肿患者血清中的CA125含量（均为术前检测，术后病理确诊）。其结果表明：卵巢癌组患者血清中CA125含量明显高于卵巢囊肿组。本结果说明：CA125可以做为鉴别诊断卵巢癌与卵巢囊肿的检验指标。
In order to find a test for the differential diagnosis of ovarian and ovarian cysts, the serum levels of CA125 in 36 patients with ovarian cancer and 32 patients with ovarian cysts were measured by IMX automated microparticle enzyme immunoassay analyzer (all preoperatively and postoperatively Pathology confirmed). The results showed that: serum CA125 levels in patients with ovarian cancer were significantly higher than those in ovarian cysts. The results show that: CA125 can be used as a differential diagnosis of ovarian cancer and ovarian cysts test indicators.